— Fast Track Designation facilitates development and expedites regulatory review of therapies addressing serious conditions with significant unmet medical need — — QRX003 lotion (4%) currently being evaluated in two late-stage whole-body clinical trials for treatment of Netherton Syndrome — — Fast Track Designation follows Pediatric Rare Disease and Orphan Drug Designation previously granted by the FDA and Orphan Drug Designation granted by the European Medicines Agency for QRX003 in Netherton Syndrome — AS ...

BOULDER, Colo., March 11, 2026 (GLOBE NEWSWIRE) -- Gaia, Inc. (NASDAQ: GAIA), a conscious media and community company, will participate in the following upcoming investor events: Sidoti Small-Cap Virtual ConferenceDate: Wednesday, March 18th – Thursday, March 19th, 2026Location: Virtual 38th Annual ROTH ConferenceDate: Sunday, March 22nd – Tuesday, March 24th, 2026Location: Dana Point, California For additional information about the events or to schedule a one-on-one meeting with Gaia, please contact GAIA@g ...

NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- Fluent, Inc. (NASDAQ: FLNT), a leading commerce media solutions provider, today announced that Don Patrick, Chief Executive Officer, and Ryan Perfit, Chief Financial Officer, will participate in the 38th Annual ROTH Conference on March 23-24 at the Ritz-Carlton Laguna Niguel in Dana Point, California. Management will be available for one-on-one meetings on Monday, March 23, and Tuesday, March 24. For more information or to register and schedule a one-on-one meeti ...

TAMPA, Fla., March 11, 2026 (GLOBE NEWSWIRE) -- AtlasClear Holdings, Inc. (NYSE American: ATCH) (“AtlasClear” or the “Company”), a financial services company building modern clearing, custody, and trading infrastructure, today announced that it will be participating in the 38th Annual ROTH Conference on March 22–24, 2026. Company executives will be available for one-on-one meetings with investors. Management will highlight the Company’s recent corporate developments and overarching strategy as AtlasClear co ...

QDPAK and Low-profile TO247 in the latest GeneSiC™ 5th Generation Trench-Assisted Planar SiC MOSFET technology deliver significant improvements in performance and lifetime for AI data centers, grid and energy infrastructure, and industrial electrification with voltage ratings of 1200 V Navitas Adds Top-Side Cooled QDPAK and Low-Profile TO-247-4L to its Package Line-Up in the Latest 5th Generation GeneSiC™ Technology QDPAK and Low-profile TO247 in the latest GeneSiC™ 5th Generation Trench-Assisted Planar S ...

SARASOTA, Fla., March 11, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-targeted therapeutics through proprietary intranasal delivery technology, today announced that it is exploring discussions with third parties regarding the potential acquisition of additional assets in the central nervous system (CNS) space, with a specific focus on brain health and brain recovery indications that demonstrate strategic synergies with the Company's ...

KWM Expands High-Tech Strategy with Second AI Technology Acquisition, Establishing Dedicated AI Division Alongside IP Content and CommercializationNEW YORK and SEOUL, South Korea, March 11, 2026 (GLOBE NEWSWIRE) -- K Wave Media Ltd. (“KWM”), a global K-content and intellectual property company, today announced that, through its wholly owned subsidiary Play Company, KWM has completed the acquisition of a 42.5% controlling stake, including management rights, in KOSDAQ-listed Hansol Inticube Co., Ltd. (“Hansol ...

SINGAPORE, March 11, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced several strategic business developments, including a significant regulatory classification in Saudi Arabia and the expansion of its Medical and Scientific Advisory Board. Regulatory Milestone in Saudi Arabia Cuprina’s 49%-owne ...

Consulting Agreement with Former Bayer Principal Scientist, BOLD Awards Healthcare Finalist Status, and Private Placement ClosingTORONTO and HAIFA, Israel, March 11, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical company developing exosome-based regenerative therapies for central nervous system injuries, today announced several developments supporting its planned growth, increasing awareness in Europe, and the closing ...

Initial Deployment Covers Key Sales Team, with Land-and-Expand Opportunity Across Workforce Representing Over $2M in Potential Annual Recurring Revenue NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- Our Bond, Inc. ("Bond") (NASDAQ: OBAI), the creator of the world's first AI-powered Preventative Personal Security platform adopted by leading multinational companies, today announced that one of the three largest telecommunications companies in the United States has deployed Bond to enhance employee safety for a ...